Director, Clinical Development (MD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kite Pharma · 17 hours ago

Director, Clinical Development (MD)

Kite Pharma is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The Medical Director will lead clinical trials in hematologic malignancies, collaborating with various stakeholders to advance CAR T-cell therapies and ensure high-quality trial delivery.

BiotechnologyHealth CareMedicalOncologyTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Provide medical monitoring to multiple oncology clinical trials
Lead project teams to design and implement clinical studies
Write protocols, investigator brochures, clinical study reports and review clinical trial documents
Conduct investigator meetings and lead site initiation visits with clinical trial investigators
Execute and deploy drug development strategic plans, develop contingency plans, provide technical and strategic advice, and meet milestones and budgets
Translate findings from research and nonclinical studies into clinical development opportunities
Interact with clinical investigators and thought leaders
Work with internal regulatory affairs team and other ethical guidelines relevant to the pharmaceutical industry, and ensure compliance with these external guidelines
Work with internal pre-clinical scientists, translational scientists, business and commercial organizations in a cross functional manner
Work in a team environment comprising clinical operations, biomarker specialists, CROs, and regulatory affairs
Perform other duties as required
Support, provide input into regulatory filing documents, conduct regulatory filings

Qualification

MDEquivalentOncology trials managementClinical trial designBoard certification in HematologyDrug development experienceClinical development strategyCross-functional collaborationCommunicationProblem-solving skillsTeamwork

Required

MD or equivalent with 4+ years of experience managing oncology trials

Preferred

Board certification/specialization in Hematology or Oncology
At least 2 years of relevant drug development experience, either within industry or as a clinical investigator/physician scientist in academia, or equivalent experience
Proven clinical development strategist with experience designing, implementing and conducting clinical trials, with emphasis on proof-of-concept and first-in-human studies
Knowledge of carrying out hematology/oncology clinical trials, including knowledge of hematology/oncology treatment options
Strategic leadership and tactical skills, excellent initiative and judgment, and demonstrated ability to positively represent the goals of Kite
Demonstrated ability to develop and maintain excellent working relationships with both internal colleagues and external contacts, including key thought leaders, and investigators
Demonstrated ability to work well in teams in a cross functional manner
Ability to communicate and work independently with scientific/technical personnel
Ability to think critically, and demonstrated troubleshooting and problem solving skills
Self-motivated and willing to accept temporary responsibilities outside of initial job description
Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities
May travel up to 30%

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Kite Pharma

company-logo
Kite Pharma is a biotechnology company that designs and develops immune-based therapies to treat cancer indications.

H1B Sponsorship

Kite Pharma has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (47)
2023 (54)
2022 (59)
2021 (53)
2020 (38)

Funding

Current Stage
Public Company
Total Funding
$335.38M
Key Investors
Alta Partners
2017-08-28Acquired
2015-12-10Post Ipo Equity· $250.12M
2014-06-20IPO

Leadership Team

leader-logo
Craig Vermeyen
Director, Packaging and Labeling
linkedin
leader-logo
Mark Jurgens
Executive Director, Head of External Scientific Collaboration
linkedin
Company data provided by crunchbase